Asbestos trust fund payment percentages have dropped below 10% of claim value

When asbestos manufacturers went bankrupt, courts required them to establish trust funds to compensate future victims. Over 60 trusts were created holding approximately $37 billion. But as claims mounted over decades and trusts needed to reserve funds for future claimants (since mesothelioma's 20-60 year latency means new victims will emerge for decades), trust administrators slashed payment percentages. Many trusts now pay less than 10% of a claim's scheduled value -- some as low as 1-5%. So what? A mesothelioma patient with a scheduled claim value of $180,000 might receive $9,000-$18,000 from a given trust. So what? Meanwhile, mesothelioma treatment costs average $150,000-$1,000,000 over the course of the disease, and the patient is typically too ill to work. The trust payout barely covers a single month of treatment. So what? Families are forced to pursue litigation against solvent defendants (a process taking 1-3 years) while the patient's median survival is 12-21 months -- meaning many patients die before their case resolves. The structural reason this persists: trust fund sizes were set based on actuarial estimates made decades ago that underestimated the long tail of asbestos disease, and there is no mechanism to replenish depleted trusts because the responsible companies no longer exist.